Literature DB >> 3841021

Clinical use of atracurium in myasthenia gravis: a case report.

F M Ramsey, G D Smith.   

Abstract

A patient with myasthenia gravis was anaesthetized for thymectomy utilizing atracurium for maintenance of muscle relaxation. The patient was not taking anticholinesterase medications before surgery. Neuromuscular function was monitored by recording the train-of-four response to supramaximal stimulation of the ulnar nerve. Anaesthesia was induced with thiopentone and maintained with isoflurane and N2O in oxygen. Following complete recovery from a succinylcholine block for intubation, the patient developed complete neuromuscular block within two minutes after atracurium (5 mg) was administered. Evidence of recovery commenced 12 minutes later and was complete at 72 minutes. This rate of recovery is consistent with the recovery rate from atracurium during isoflurane anaesthesia in normal patients. Atracurium appears to offer an advantage over other nondepolarizing muscle relaxants in patients with myasthenia gravis due to its shorter duration and less cumulative effect at the neuromuscular junction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3841021     DOI: 10.1007/bf03011412

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  8 in total

Review 1.  Myasthenia gravis (first of two parts).

Authors:  D B Drachman
Journal:  N Engl J Med       Date:  1978-01-19       Impact factor: 91.245

Review 2.  Myasthenia gravis (second of two parts).

Authors:  D B Drachman
Journal:  N Engl J Med       Date:  1978-01-26       Impact factor: 91.245

3.  Curare Sensitivity in steroid-treated myasthenia gravis: a case report.

Authors:  C L Lake
Journal:  Anesth Analg       Date:  1978 Jan-Feb       Impact factor: 5.108

4.  Myasthenia gravis and atracurium. A case report.

Authors:  A M Macdonald; R I Keen; N D Pugh
Journal:  Br J Anaesth       Date:  1984-06       Impact factor: 9.166

5.  Neuromuscular blockade in myasthenia gravis with atracurium besylate.

Authors:  S Ward; D J Wright
Journal:  Anaesthesia       Date:  1984-01       Impact factor: 6.955

6.  Modification of atracurium blockade by halothane and by suxamethonium. A review of clinical experience.

Authors:  J A Stirt; R L Katz; A L Murray; D L Schehl; C Lee
Journal:  Br J Anaesth       Date:  1983       Impact factor: 9.166

7.  Pharmacokinetics, pharmacodynamics and dose-response relationships of atracurium administered i.v.

Authors:  B C Weatherley; S G Williams; E A Neill
Journal:  Br J Anaesth       Date:  1983       Impact factor: 9.166

8.  Safety and efficacy of atracurium (BW33A) in surgical patients receiving balanced or isoflurane anesthesia.

Authors:  M D Sokoll; S D Gergis; M Mehta; N M Ali; C Lineberry
Journal:  Anesthesiology       Date:  1983-05       Impact factor: 7.892

  8 in total
  1 in total

1.  Cumulative dose-response curves for atracurium in patients with myasthenia gravis.

Authors:  C E Smith; F Donati; D R Bevan
Journal:  Can J Anaesth       Date:  1989-07       Impact factor: 5.063

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.